Table 4.
Resource Utilization and Safety Metricsa
| Outcome | Preintervention (n=251) | Postintervention (n=101) | P value |
|---|---|---|---|
| Hospital stay (d), median (IQR) | 4 (2-8) | 4 (3-9.5) | .07 |
| IV insulin therapy duration (h), median (IQR) | 19 (15-27.5) | 20 (15-28) | .55 |
| Posttransition hyperglycemia (>250 mg/dL)b within the 12 h following IV to SC insulin transition, n (%) | 115 (45.8) | 39 (38.6) | .21 |
| Posttransition hypoglycemia, n (%) | 27 (10.7) | 4 (4.0) | .04 |
| Rebound DKA, n (%) | 17 (6.8) | 7 (6.9) | .97 |
| Death during hospital stay, n (%) | 6 (2.4) | 2 (2.0) | .82 |
a
DKA, diabetic ketoacidosis; IQR, interquartile range; IV, intravenous; SC, subcutaneous.
b
SI conversion factors: To convert posttransition hyperglycemia values to mmol/L, multiply by 0.0259.